CodeLab Capital AS (OSL:CODE)
Norway · Delayed Price · Currency is NOK 2.460
-0.020 (-0.81%)
Oct 3, 2025, 3:56 PM CET
CodeLab Capital AS Revenue
CodeLab Capital AS had revenue of 3.75K NOK in the half year ending June 30, 2025, a decrease of -99.99%. This brings the company's revenue in the last twelve months to 161.95K, down -94.39% year-over-year. In the year 2024, CodeLab Capital AS had annual revenue of 249.39K, down -99.58%.
Revenue (ttm)
161.95K
Revenue Growth
-94.39%
P/S Ratio
198.12
Revenue / Employee
5.78K
Employees
28
Market Cap
32.09M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 249.39K | -58.92M | -99.58% |
| Dec 31, 2023 | 59.17M | -135.83M | -69.66% |
| Dec 31, 2022 | 195.01M | -13.63M | -6.53% |
| Dec 31, 2021 | 208.63M | 68.85M | 49.26% |
| Dec 31, 2020 | 139.78M | 24.97M | 21.75% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medistim ASA | 628.08M |
| Nordhealth AS | 578.17M |
| Photocure ASA | 522.86M |
| ArcticZymes Technologies ASA | 104.33M |
| Omda AS | 458.96M |
| Vistin Pharma ASA | 452.25M |
| Gentian Diagnostics ASA | 163.38M |
| Nykode Therapeutics AS | 79.85M |